Aravind Palraj / X
Jul 22, 2025, 09:17
Decoding Antiphospholipid Syndrome: Why Triple Positivity Is a Red Flag for Thrombosis
Aravind Palraj, MD highlights a crucial message on his X page:
”Antiphospholipid antibodies (aPL) are key to diagnosing APS—but timing, type, and persistence matter.
Triple positive? Highest thrombosis risk.
Test smart. Interpret wisely.”
Want to dive deeper into Antiphospholipid Syndrome?
On Hemostasis Today, you can explore in-depth, clinically relevant, and first-hand academic knowledge on:
- Diagnostic strategies for APS
- Role of Lupus Anticoagulant, anticardiolipin, and β2-GPI antibodies
- Risk stratification and management approaches in triple-positive patients
- Anticoagulation dilemmas in APS
-
Nov 2, 2026, 02:56Leonhard Stärk: The Future of Universal Donor-Free Red Blood Cells
-
Nov 2, 2026, 02:45Marija Tashkovska: Advancing Transfusion Medicine Through Collaboration
-
Nov 2, 2026, 02:32Rachel Rosovsky: Pulmonary Embolism During Pregnancy and Postpartum
-
Nov 2, 2026, 02:26Jaromir Vajter: Bleeding Risks and Anticoagulation After ECPR
-
Nov 2, 2026, 02:13Maia Meier: 111 Kilometres on Skis to the South Pole
-
Nov 1, 2026, 23:49Austin Reese: Should Anticoagulation for AF Continue When Patients Move into Long-Term Care?
-
Nov 1, 2026, 23:43Abdelmonam Hagag: Mechanical Thrombectomy vs Anticoagulation in Acute Pulmonary Embolism New Meta Analysis
-
Nov 1, 2026, 23:38Ankur Garg: Safe Water and Nutrition as Economic Investments for LMIC Demographic Dividends
-
Nov 1, 2026, 23:30Ana Paula Tagliari: FIH Experience with Penumbra Lightning Flash 2.0 at TCT 2026